Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06822322 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06822322 · ClinicalTrials.gov record · last posted 2025-02-14

The European Bifurcation Club Randomized Trial of Stepwise Provisional Stenting Versus Drug Coated Balloon Therapy for Non-left Main True Coronary Bifurcations

Study acronym: EBC DCB
StatusNot Yet Recruiting
PhaseNot applicable
Started2025-05
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Clinical outcomes are worse in patients with coronary artery bifurcation lesions, even if commonly encountered in clinical practice. The use of drug coated balloons within bifurcation lesions offers the acute advantage of a more straightforward procedure, without recrossing and deformation of a stent. Thus, the primary objective of this study is to determine if Drug Coated Balloon treatment of non-left main true coronary artery bifurcation lesions is non-inferior (similar) to a provisional strategy with Drug Eluted Stent deployment.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2025-02-06. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details
NCT Number NCT06822322
Lead Sponsor Ceric Sàrl
Collaborators: European Cardiovascular Research Center
Conditions Coronary Artery Disease (non-left Main), Coronary Bifurcation Lesion
Enrollment 750 participants
Start Date 2025-05
Primary Completion 2028-05 (estimated)
Study Completion 2035-08 (estimated)
Updated on ClinicalTrials.gov 2025-02-14